Evotec, Takeda partner on RNA-targeting drug discovery, development

By The Science Advisory Board staff writers

March 22, 2021 -- Evotec has entered into an alliance with Takeda Pharmaceutical with the goal of discovering and developing RNA-targeting small-molecule therapeutics for targets that are difficult to address with conventional approaches.

Together, the companies will jointly identify and develop small molecules targeting a range of RNA targets aligned with Takeda's research and development areas. The collaboration will leverage Evotec's RNA-targeting platform to optimally identify promising RNA sequences to target with small-molecule ligands that can potentially be developed into first-in-class therapeutics.

Evotec's platform uses structure-based recognition of RNA tertiary structures as an alternative to sequence-based approaches. RNA-targeting small-molecule approaches enable novel therapeutics by allowing highly conserved parts of RNA, creating pathways where encoded proteins cannot be targeted with conventional targeted approaches.

Under the agreement, Evotec will receive significant research funding and will be eligible to receive discovery, preclinical, clinical, commercial, and sales milestone payments of up to $160 million per program. Additionally, Evotec is entitled to tiered royalties on net sales of any product resulting from the collaboration.


Copyright © 2021 scienceboard.net
 
To access all The ScienceBoard content create a free account now:


Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.


Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Already have an account? Sign in here